Exploring the safety of COVID-19 mRNA vaccines in the elderly

Researchers evaluate the risks of possible adverse events following COVID-19 mRNA vaccination in the elderly.

Formycon and Fresenius Kabi announce File Acceptance for FYB202, a biosimilar candidate to Stelara® (ustekinumab), by the U.S. Food and Drug Administration – Biotech Investments

EQS-News: Formycon AG / Key word(s): Regulatory Admission Formycon and Fresenius Kabi announce File Acceptance for FYB202, a biosimilar candidate to Stelara® (ustekinumab), by the

December 1, 2023

Emergent scores US medical countermeasure contracts worth over $250m

The contract modifications are for Emergent’s current ten-year contracts with the US Department of Health and Human Services. Image Credit: Images Products / Shutterstock. Emergent

July 3, 2024

FDA approves Delcath’s liver-directed therapy for metastatic uveal melanoma – Pharmaceutical Technology

The Hepzato Kit has been approved in Europe since 2012 and is marketed as Chemosat hepatic delivery system for liver cancers. Image Credit: JHVEPhoto /

August 15, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.